| Financial Year |
March 31 2023 |
| Monetary Funds |
18,176,700.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
87,229,152.99 |
| Accounts Receivable |
191,011,554.14 |
| Advances to Suppliers |
17,222,344.14 |
| Other Receivables |
22,690,383.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
209,233,260.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,624,886.08 |
| Total Current Assets |
556,917,078.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
96,733,994.97 |
| Investment Properties |
-- |
| Fixed Assetes |
389,875,471.49 |
| Under-construction Projects |
111,187,574.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,570,773.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,208,383.39 |
| Deferred Income Tax Assets |
3,391,205.93 |
| Other Non-Current Assets |
17,532,998.95 |
| Sub-Total of Non-Current Assets |
727,440,688.85 |
| Total Assets |
1,284,357,766.99 |
| Short-Term Loans |
221,530,095.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
79,356,248.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,877,422.56 |
| Taxes Payable |
15,167,511.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,687,227.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
639,167.27 |
| Sub-Total of Current Liabilities |
344,183,965.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,430,589.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,735,032.18 |
| Total Liabilities |
353,918,997.31 |
| Paid-In Capital(Or Share Stock) |
104,216,043.00 |
| Capital Surplus |
353,516,966.68 |
| Surplus Reserve |
44,054,610.02 |
| LESS:Treasury Stock |
274,736.00 |
| Undistributed Profits |
399,087,007.58 |
| Minority Stockholder's Interest |
26,228,349.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
904,210,419.95 |
| Owner's Equity（Stockholder's Equity） |
930,438,769.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,284,357,766.99 |
